Add to ORKGInhaled nitric oxide in hypoxaemic newborns who are candidates for extracorporeal life suppor
The 21st century began with the FDA approval of inhaled nitric oxide therapy for the treatment of ne...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pu...
Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COP
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrom
Pulmonary function during the first year of life in healthy infants born prematurel
The aim of this study was to evaluate the effect of inhaled nitric oxide (NO) in newborns with acute...
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel ...
Supplemental oxygen and nasal intermittent positive pressure ventilation A.J. Padkin*, W.J.M. Kinnea...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because ...
Inhaled nitric oxide (NO) has been recently proposed as a new treatment in newborns and children wit...
SIGLEAvailable from British Library Document Supply Centre-DSC:DXN022329 / BLDSC - British Library D...
The 21st century began with the FDA approval of inhaled nitric oxide therapy for the treatment of ne...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pu...
Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COP
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrom
Pulmonary function during the first year of life in healthy infants born prematurel
The aim of this study was to evaluate the effect of inhaled nitric oxide (NO) in newborns with acute...
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel ...
Supplemental oxygen and nasal intermittent positive pressure ventilation A.J. Padkin*, W.J.M. Kinnea...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because ...
Inhaled nitric oxide (NO) has been recently proposed as a new treatment in newborns and children wit...
SIGLEAvailable from British Library Document Supply Centre-DSC:DXN022329 / BLDSC - British Library D...
The 21st century began with the FDA approval of inhaled nitric oxide therapy for the treatment of ne...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pu...